{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:12:39Z","timestamp":1780341159344,"version":"3.54.1"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T00:00:00Z","timestamp":1489190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10143-017-0837-9","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T01:14:51Z","timestamp":1489194891000},"page":"931-944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macrophages, and possible therapeutic implications: a comprehensive review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-9939","authenticated-orcid":false,"given":"Yosef","family":"Laviv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard M.","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,11]]},"reference":[{"key":"837_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007074420772","volume":"20","author":"NJ Abbott","year":"2000","unstructured":"Abbott NJ (2000) Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20:131\u2013147","journal-title":"Cell Mol Neurobiol"},{"key":"837_CR2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.20061931","volume":"204","author":"RA Adams","year":"2007","unstructured":"Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, Degen JL, Akassoglou K (2007) The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med 204:571\u2013582","journal-title":"J Exp Med"},{"key":"837_CR3","first-page":"163","volume":"4","author":"RA Adams","year":"2004","unstructured":"Adams RA, Passino M, Sachs BD, Nuriel T, Akassoglou K (2004) Fibrin mechanisms and functions in nervous system pathology. Mol Interv 4:163\u2013176","journal-title":"Mol Interv"},{"key":"837_CR4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3171\/2014.6.JNS131433","volume":"121","author":"S Agnihotri","year":"2014","unstructured":"Agnihotri S, Gugel I, Remke M, Bornemann A, Pantazis G, Mack SC, Shih D, Singh SK, Sabha N, Taylor MD et al (2014) Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma. J Neurosurg 121:1434\u20131445","journal-title":"J Neurosurg"},{"key":"837_CR5","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","volume":"24","author":"DA Altomare","year":"2005","unstructured":"Altomare DA, Testa JR (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24:7455\u20137464","journal-title":"Oncogene"},{"key":"837_CR6","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1128\/MCB.25.17.7546-7556.2005","volume":"25","author":"J An","year":"2005","unstructured":"An J, Rettig MB (2005) Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity. Mol Cell Biol 25:7546\u20137556","journal-title":"Mol Cell Biol"},{"key":"837_CR7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1067\/mjd.2002.120530","volume":"46","author":"JL Arbiser","year":"2002","unstructured":"Arbiser JL, Brat D, Hunter S, D\u2019Armiento J, Henske EP, Arbiser ZK, Bai X, Goldberg G, Cohen C, Weiss SW (2002) Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. J Am Acad Dermatol 46:376\u2013380","journal-title":"J Am Acad Dermatol"},{"key":"837_CR8","doi-asserted-by":"crossref","first-page":"L1447","DOI":"10.1152\/ajplung.00262.2015","volume":"309","author":"EN Atochina-Vasserman","year":"2015","unstructured":"Atochina-Vasserman EN, Abramova E, James ML, Rue R, Liu AY, Ersumo NT, Guo CJ, Gow AJ, Krymskaya VP (2015) Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis. Am J Physiol Lung Cell Mol Physiol 309:L1447\u2013L1454","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"837_CR9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000017351","volume":"20","author":"SY Baek","year":"1998","unstructured":"Baek SY, Kim SU (1998) Proliferation of human Schwann cells induced by neu differentiation factor isoforms. Dev Neurosci 20:512\u2013517","journal-title":"Dev Neurosci"},{"key":"837_CR10","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/foc.2007.22.5.10","volume":"22","author":"MA Baggenstos","year":"2007","unstructured":"Baggenstos MA, Butman JA, Oldfield EH, Lonser RR (2007) Role of edema in peritumoral cyst formation. Neurosurg Focus 22:E9","journal-title":"Neurosurg Focus"},{"key":"837_CR11","doi-asserted-by":"crossref","unstructured":"Bardehle S, Rafalski VA, Akassoglou K (2015) Breaking boundaries\u2014coagulation and fibrinolysis at the neurovascular interface. Front Cell Neurosci 9","DOI":"10.3389\/fncel.2015.00354"},{"key":"837_CR12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cvr\/cvq105","volume":"87","author":"DO Bates","year":"2010","unstructured":"Bates DO (2010) Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87:262\u2013271","journal-title":"Cardiovasc Res"},{"key":"837_CR13","doi-asserted-by":"crossref","unstructured":"Blakeley JO, Ye X, Duda DG, Halpin CF, Bergner AL, Muzikansky A, Merker VL, Gerstner ER, Fayad LM, Ahlawat S et al (2016) Efficacy and biomarker study of bevacizumab for hearing loss resulting from neurofibromatosis type 2-associated vestibular schwannomas. J Clin Oncol 14","DOI":"10.1200\/JCO.2015.64.3817"},{"key":"837_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2007.10.002","volume":"78","author":"K Boer","year":"2008","unstructured":"Boer K, Jansen F, Nellist M, Redeker S, van den Ouweland AM, Spliet WG, van Nieuwenhuizen O, Troost D, Crino PB, Aronica E (2008) Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 78:7\u201321","journal-title":"Epilepsy Res"},{"key":"837_CR15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3171\/jns.1987.67.6.0880","volume":"67","author":"JN Bruce","year":"1987","unstructured":"Bruce JN, Criscuolo GR, Merrill MJ, Moquin RR, Blacklock JB, Oldfield EH (1987) Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. J Neurosurg 67:880\u2013884","journal-title":"J Neurosurg"},{"key":"837_CR16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jcp.29.4.341","volume":"29","author":"MJ Brueton","year":"1976","unstructured":"Brueton MJ, Breeze GR, Stuart J (1976) Fibrin-fibrinogen degradation products in cerebrospinal fluid. J Clin Pathol 29:341\u2013344","journal-title":"J Clin Pathol"},{"key":"837_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2004.06.020","volume":"6","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas J, Kaelin WG Jr (2004) Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell 6:7\u201310","journal-title":"Cancer Cell"},{"key":"837_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","volume":"4","author":"JB Brugarolas","year":"2003","unstructured":"Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG Jr (2003) TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4:147\u2013158","journal-title":"Cancer Cell"},{"key":"837_CR19","doi-asserted-by":"crossref","unstructured":"Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T (2013) The TSC-mTOR pathway regulates macrophage polarization. Nat Commun 4","DOI":"10.1038\/ncomms3834"},{"key":"837_CR20","doi-asserted-by":"crossref","first-page":"e955356","DOI":"10.4161\/21624011.2014.955356","volume":"3","author":"MA Cannarile","year":"2014","unstructured":"Cannarile MA, Ries CH, Hoves S, Ruttinger D (2014) Targeting tumor-associated macrophages in cancer therapy and understanding their complexity. Oncoimmunology 3:e955356 eCollection 952014 Oct","journal-title":"Oncoimmunology"},{"key":"837_CR21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00129492-200501000-00017","volume":"26","author":"P Caye-Thomasen","year":"2005","unstructured":"Caye-Thomasen P, Werther K, Nalla A, Bog-Hansen TC, Nielsen HJ, Stangerup SE, Thomsen J (2005) VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 26:98\u2013101","journal-title":"Otol Neurotol"},{"key":"837_CR22","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/JVI.03149-13","volume":"88","author":"Q Chai","year":"2014","unstructured":"Chai Q, He WQ, Zhou M, Lu H, Fu ZF (2014) Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines\/cytokines induced by rabies virus infection. J Virol 88:4698\u20134710","journal-title":"J Virol"},{"key":"837_CR23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2741\/1796","volume":"11","author":"AJ Chu","year":"2006","unstructured":"Chu AJ (2006) Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit. Front Biosci 11:256\u2013271","journal-title":"Front Biosci"},{"key":"837_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009734.2015.1064501","volume":"120","author":"L Claesson-Welsh","year":"2015","unstructured":"Claesson-Welsh L (2015) Vascular permeability\u2014the essentials. Ups J Med Sci 120:135\u2013143","journal-title":"Ups J Med Sci"},{"key":"837_CR25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","volume":"273","author":"L Claesson-Welsh","year":"2013","unstructured":"Claesson-Welsh L, Welsh M (2013) VEGFA and tumour angiogenesis. J Intern Med 273:114\u2013127","journal-title":"J Intern Med"},{"key":"837_CR26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI114322","volume":"84","author":"DT Connolly","year":"1989","unstructured":"Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470\u20131478","journal-title":"J Clin Invest"},{"key":"837_CR27","first-page":"277","volume":"66","author":"GR Criscuolo","year":"1993","unstructured":"Criscuolo GR (1993) The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. Yale J Biol Med 66:277\u2013314","journal-title":"Yale J Biol Med"},{"key":"837_CR28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3171\/jns.1988.69.2.0254","volume":"69","author":"GR Criscuolo","year":"1988","unstructured":"Criscuolo GR, Merrill MJ, Oldfield EH (1988) Further characterization of malignant glioma-derived vascular permeability factor. J Neurosurg 69:254\u2013262","journal-title":"J Neurosurg"},{"key":"837_CR29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0028-1096198","volume":"18","author":"DM Dalgorf","year":"2008","unstructured":"Dalgorf DM, Rowsell C, Bilbao JM, Chen JM (2008) Immunohistochemical investigation of hormone receptors and vascular endothelial growth factor concentration in vestibular schwannoma. Skull Base 18:377\u2013384","journal-title":"Skull Base"},{"key":"837_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-00011-00290-00288","volume":"34","author":"D Davalos","year":"2012","unstructured":"Davalos D, Akassoglou K (2012) Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 34:43\u201362. doi: 10.1007\/s00281-00011-00290-00288","journal-title":"Semin Immunopathol"},{"key":"837_CR31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MAO.0b013e31827c9fbf","volume":"34","author":"M Vries de","year":"2013","unstructured":"de Vries M, Briaire-de Bruijn I, Malessy MJ, de Bruine SF, van der Mey AG, Hogendoorn PC (2013) Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas. Otol Neurotol 34:347\u2013352","journal-title":"Otol Neurotol"},{"key":"837_CR32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.molonc.2015.03.009","volume":"9","author":"S Dilwali","year":"2015","unstructured":"Dilwali S, Briet MC, Kao SY, Fujita T, Landegger LD, Platt MP, Stankovic KM (2015) Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth. Mol Oncol 9:1359\u20131370","journal-title":"Mol Oncol"},{"key":"837_CR33","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1096\/fasebj.8.15.8001745","volume":"8","author":"CA Dinarello","year":"1994","unstructured":"Dinarello CA (1994) The interleukin-1 family: 10 years of discovery. FASEB J 8:1314\u20131325","journal-title":"FASEB J"},{"key":"837_CR34","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd KM, Yang J, Shen MH, Sampson JR, Tee AR (2015) mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34:2239\u20132250","journal-title":"Oncogene"},{"key":"837_CR35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cvr\/cvq139","volume":"87","author":"WN Duran","year":"2010","unstructured":"Duran WN, Breslin JW, Sanchez FA (2010) The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res 87:254\u2013261","journal-title":"Cardiovasc Res"},{"key":"837_CR36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.1992.tb51603.x","volume":"667","author":"HF Dvorak","year":"1992","unstructured":"Dvorak HF, Nagy JA, Berse B, Brown LF, Yeo KT, Yeo TK, Dvorak AM, van de Water L, Sioussat TM, Senger DR (1992) Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci 667:101\u2013111","journal-title":"Ann N Y Acad Sci"},{"key":"837_CR37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9:550\u2013562","journal-title":"Nat Rev Cancer"},{"key":"837_CR38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.soc.2013.06.011","volume":"22","author":"DJ Erstad","year":"2013","unstructured":"Erstad DJ, Cusack JC Jr (2013) Targeting the NF-kappaB pathway in cancer therapy. Surg Oncol Clin N Am 22:705\u2013746","journal-title":"Surg Oncol Clin N Am"},{"key":"837_CR39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3171\/2011.6.JNS11131","volume":"115","author":"B Fong","year":"2011","unstructured":"Fong B, Barkhoudarian G, Pezeshkian P, Parsa AT, Gopen Q, Yang I (2011) The molecular biology and novel treatments of vestibular schwannomas. J Neurosurg 115:906\u2013914","journal-title":"J Neurosurg"},{"key":"837_CR40","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604\u20134613","journal-title":"Mol Cell Biol"},{"key":"837_CR41","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","volume":"15","author":"DN Franz","year":"2014","unstructured":"Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY et al (2014) Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol 15:1513\u20131520","journal-title":"Lancet Oncol"},{"key":"837_CR42","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1073\/pnas.041359198","volume":"98","author":"D Fukumura","year":"2001","unstructured":"Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A 98:2604\u20132609","journal-title":"Proc Natl Acad Sci U S A"},{"key":"837_CR43","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1158\/1541-7786.MCR-15-0213","volume":"13","author":"Y Gao","year":"2015","unstructured":"Gao Y, Gartenhaus RB, Lapidus RG, Hussain A, Zhang Y, Wang X, Dan HC (2015) Differential IKK\/NF-kappaB activity is mediated by TSC2 through mTORC1 in PTEN-null prostate cancer and tuberous sclerosis complex tumor cells. Mol Cancer Res 13:1602\u20131614","journal-title":"Mol Cancer Res"},{"key":"837_CR44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrclinonc.2009.14","volume":"6","author":"ER Gerstner","year":"2009","unstructured":"Gerstner ER, Duda DG, di Tomaso E, Ryg PA, Loeffler JS, Sorensen AG, Ivy P, Jain RK, Batchelor TT (2009) VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. Nat Rev Clin Oncol 6:229\u2013236","journal-title":"Nat Rev Clin Oncol"},{"key":"837_CR45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ccr.2006.08.007","volume":"10","author":"S Ghosh","year":"2006","unstructured":"Ghosh S, Tergaonkar V, Rothlin CV, Correa RG, Bottero V, Bist P, Verma IM, Hunter T (2006) Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival. Cancer Cell 10:215\u2013226","journal-title":"Cancer Cell"},{"key":"837_CR46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1074\/jbc.M111.304337","volume":"287","author":"EJ Glidden","year":"2012","unstructured":"Glidden EJ, Gray LG, Vemuru S, Li D, Harris TE, Mayo MW (2012) Multiple site acetylation of rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein. J Biol Chem 287:581\u2013588","journal-title":"J Biol Chem"},{"key":"837_CR47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23\u201335","journal-title":"Nat Rev Immunol"},{"key":"837_CR48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11060-014-1710-0","volume":"122","author":"S Goutagny","year":"2015","unstructured":"Goutagny S, Raymond E, Esposito-Farese M, Trunet S, Mawrin C, Bernardeschi D, Larroque B, Sterkers O, Giovannini M, Kalamarides M (2015) Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas. J Neuro-Oncol 122:313\u2013320","journal-title":"J Neuro-Oncol"},{"key":"837_CR49","first-page":"139","volume":"48","author":"W Grajkowska","year":"2010","unstructured":"Grajkowska W, Kotulska K, Jurkiewicz E, Matyja E (2010) Brain lesions in tuberous sclerosis complex. Review. Folia Neuropathol 48:139\u2013149","journal-title":"Folia Neuropathol"},{"key":"837_CR50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1432-2277.2004.00026.x","volume":"18","author":"M Guba","year":"2005","unstructured":"Guba M, Koehl GE, Neppl E, Doenecke A, Steinbauer M, Schlitt HJ, Jauch KW, Geissler EK (2005) Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer. Transpl Int 18:89\u201394","journal-title":"Transpl Int"},{"key":"837_CR51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9\u201322","journal-title":"Cancer Cell"},{"key":"837_CR52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20080108","volume":"205","author":"T Hagemann","year":"2008","unstructured":"Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC, Balkwill FR (2008) \u201cRe-educating\u201d tumor-associated macrophages by targeting NF-kappaB. J Exp Med 205:1261\u20131268","journal-title":"J Exp Med"},{"key":"837_CR53","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/glia.20316","volume":"53","author":"MR Hansen","year":"2006","unstructured":"Hansen MR, Roehm PC, Chatterjee P, Green SH (2006) Constitutive neuregulin-1\/ErbB signaling contributes to human vestibular schwannoma proliferation. Glia 53:593\u2013600","journal-title":"Glia"},{"key":"837_CR54","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1091\/mbc.e13-07-0405","volume":"24","author":"Y He","year":"2013","unstructured":"He Y, Li D, Cook SL, Yoon MS, Kapoor A, Rao CV, Kenis PJ, Chen J, Wang F (2013) Mammalian target of rapamycin and rictor control neutrophil chemotaxis by regulating Rac\/Cdc42 activity and the actin cytoskeleton. Mol Biol Cell 24:3369\u20133380","journal-title":"Mol Biol Cell"},{"key":"837_CR55","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1200\/JCO.2014.56.2082","volume":"33","author":"TJ Hobday","year":"2015","unstructured":"Hobday TJ, Qin R, Reidy-Lagunes D, Moore MJ, Strosberg J, Kaubisch A, Shah M, Kindler HL, Lenz HJ, Chen H et al (2015) Multicenter phase II trial of temsirolimus and bevacizumab in pancreatic neuroendocrine tumors. J Clin Oncol 33:1551\u20131556","journal-title":"J Clin Oncol"},{"key":"837_CR56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549\u2013580","journal-title":"Pharmacol Rev"},{"key":"837_CR57","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12:1476\u20134598","journal-title":"Mol Cancer"},{"key":"837_CR58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1160\/TH06-08-0470","volume":"97","author":"E Hofer","year":"2007","unstructured":"Hofer E, Schweighofer B (2007) Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis. Thromb Haemost 97:355\u2013363","journal-title":"Thromb Haemost"},{"key":"837_CR59","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/MCB.01392-08","volume":"29","author":"SS Houshmandi","year":"2009","unstructured":"Houshmandi SS, Emnett RJ, Giovannini M, Gutmann DH (2009) The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner. Mol Cell Biol 29:1472\u20131486","journal-title":"Mol Cell Biol"},{"key":"837_CR60","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","volume":"28","author":"J Huang","year":"2008","unstructured":"Huang J, Dibble CC, Matsuzaki M, Manning BD (2008) The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 28:4104\u20134115","journal-title":"Mol Cell Biol"},{"key":"837_CR61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","volume":"37","author":"J Huang","year":"2009","unstructured":"Huang J, Manning BD (2009) A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 37:217\u2013222","journal-title":"Biochem Soc Trans"},{"key":"837_CR62","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1128\/JCM.00802-12","volume":"50","author":"M Hugelshofer","year":"2012","unstructured":"Hugelshofer M, Achermann Y, Kovari H, Dent W, Hombach M, Bloemberg G (2012) Meningoencephalitis with subdural empyema caused by toxigenic Clostridium perfringens type a. J Clin Microbiol 50:3409\u20133411","journal-title":"J Clin Microbiol"},{"key":"837_CR63","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1096\/fj.01-0658com","volume":"16","author":"R Humar","year":"2002","unstructured":"Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ (2002) Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 16:771\u2013780","journal-title":"FASEB J"},{"key":"837_CR64","doi-asserted-by":"crossref","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","volume":"2","author":"A Israel","year":"2010","unstructured":"Israel A (2010) The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2:a000158","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"837_CR65","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, Hall MN (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6:1122\u20131128","journal-title":"Nat Cell Biol"},{"key":"837_CR66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0975-7406.76489","volume":"3","author":"S Jain","year":"2011","unstructured":"Jain S, Gautam V, Naseem S (2011) Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci 3:118\u2013127","journal-title":"J Pharm Bioallied Sci"},{"key":"837_CR67","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","volume":"29","author":"MF James","year":"2009","unstructured":"James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, Gusella JF, Ramesh V (2009) NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol 29:4250\u20134261","journal-title":"Mol Cell Biol"},{"key":"837_CR68","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1541-7786.MCR-11-0425-T","volume":"10","author":"MF James","year":"2012","unstructured":"James MF, Stivison E, Beauchamp R, Han S, Li H, Wallace MR, Gusella JF, Stemmer-Rachamimov AO, Ramesh V (2012) Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types. Mol Cancer Res 10:649\u2013659","journal-title":"Mol Cancer Res"},{"key":"837_CR69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0065-230X(09)02002-8","volume":"102","author":"BH Jiang","year":"2009","unstructured":"Jiang BH, Liu LZ (2009) PI3K\/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102:19\u201365","journal-title":"Adv Cancer Res"},{"key":"837_CR70","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbapap.2007.09.008","volume":"1784","author":"BH Jiang","year":"2008","unstructured":"Jiang BH, Liu LZ (2008) PI3K\/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784:150\u2013158","journal-title":"Biochim Biophys Acta"},{"key":"837_CR71","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/neuonc\/not150","volume":"16","author":"MA Karajannis","year":"2014","unstructured":"Karajannis MA, Legault G, Hagiwara M, Giancotti FG, Filatov A, Derman A, Hochman T, Goldberg JD, Vega E, Wisoff JH et al (2014) Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro-Oncology 16:292\u2013297","journal-title":"Neuro-Oncology"},{"key":"837_CR72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3171\/jns.1979.50.1.0081","volume":"50","author":"V Kasantikul","year":"1979","unstructured":"Kasantikul V, Netsky MG (1979) Combined neurilemmoma and angioma. Tumor of ectomesenchyme and a source of bleeding. J Neurosurg 50:81\u201387","journal-title":"J Neurosurg"},{"key":"837_CR73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-002-0646-1","volume":"105","author":"S Kato","year":"2003","unstructured":"Kato S, Esumi H, Hirano A, Kato M, Asayama K, Ohama E (2003) Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki-67 antigen (MIB-1) and p53 protein. Acta Neuropathol 105:333\u2013340","journal-title":"Acta Neuropathol"},{"key":"837_CR74","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0006-291X(02)02077-6","volume":"296","author":"JY Kim","year":"2002","unstructured":"Kim JY, Kim H, Jeun SS, Rha SJ, Kim YH, Ko YJ, Won J, Lee KH, Rha HK, Wang YP (2002) Inhibition of NF-kappaB activation by merlin. Biochem Biophys Res Commun 296:1295\u20131302","journal-title":"Biochem Biophys Res Commun"},{"key":"837_CR75","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.4049\/jimmunol.180.7.4586","volume":"180","author":"MS Kim","year":"2008","unstructured":"Kim MS, Kuehn HS, Metcalfe DD, Gilfillan AM (2008) Activation and function of the mTORC1 pathway in mast cells. J Immunol 180:4586\u20134595","journal-title":"J Immunol"},{"key":"837_CR76","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2174\/138161209787846685","volume":"15","author":"E Korpos","year":"2009","unstructured":"Korpos E, Wu C, Sorokin L (2009) Multiple roles of the extracellular matrix in inflammation. Curr Pharm Des 15:1349\u20131357","journal-title":"Curr Pharm Des"},{"issue":"suppl","key":"837_CR77","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1200\/jco.2015.33.15_suppl.4005","volume":"33","author":"MH Kulke","year":"2015","unstructured":"Kulke MH, Niedzwiecki D, Foster NR, Fruth B, Kunz PL, Kennecke HF, Wolin EM, Venook AP (2015) Randomized phase II study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts) with locally advanced or metastatic pancreatic neuroendocrine tumors (pNET), CALGB 80701 (Alliance). J Clin Oncol 33(suppl) abstr:4005. doi: 10.1200\/jco.2015.33.15_suppl.4005","journal-title":"J Clin Oncol"},{"key":"837_CR78","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/mvre.2001.2338","volume":"62","author":"BK Lal","year":"2001","unstructured":"Lal BK, Varma S, Pappas PJ, Hobson RW 2nd, Duran WN (2001) VEGF increases permeability of the endothelial cell monolayer by activation of PKB\/Akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc Res 62:252\u2013262","journal-title":"Microvasc Res"},{"key":"837_CR79","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-08-2057","volume":"15","author":"HA Lane","year":"2009","unstructured":"Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR et al (2009) mTOR inhibitor RAD001 (everolimus) has antiangiogenic\/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Clin Cancer Res 15:1612\u20131622","journal-title":"Clin Cancer Res"},{"key":"837_CR80","doi-asserted-by":"crossref","unstructured":"Laoui D, Van Overmeire E, De Baetselier P, Van Ginderachter JA, Raes G (2014) Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression. Front Immunol 5","DOI":"10.3389\/fimmu.2014.00489"},{"key":"837_CR81","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293","journal-title":"Cell"},{"key":"837_CR82","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1:a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"837_CR83","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ejcb.2010.05.001","volume":"89","author":"M Leidi","year":"2010","unstructured":"Leidi M, Mariotti M, Maier JA (2010) EDF-1 contributes to the regulation of nitric oxide release in VEGF-treated human endothelial cells. Eur J Cell Biol 89:654\u2013660","journal-title":"Eur J Cell Biol"},{"issue":"10\u201312","key":"837_CR84","first-page":"14","volume":"30","author":"M Levi","year":"2010","unstructured":"Levi M (2010) The coagulant response in sepsis and inflammation. Hamostaseologie 30(10\u201312):14\u201316","journal-title":"Hamostaseologie"},{"key":"837_CR85","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","volume":"15","author":"M Levi","year":"2005","unstructured":"Levi M, van der Poll T (2005) Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 15:254\u2013259","journal-title":"Trends Cardiovasc Med"},{"key":"837_CR86","doi-asserted-by":"crossref","first-page":"014","DOI":"10.1186\/1471-2172-15-14","volume":"15","author":"HY Lin","year":"2014","unstructured":"Lin HY, Chang KT, Hung CC, Kuo CH, Hwang SJ, Chen HC, Hung CH, Lin SF (2014) Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokines. BMC Immunol 15:014\u20130037","journal-title":"BMC Immunol"},{"key":"837_CR87","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1128\/MCB.01578-08","volume":"29","author":"MA Lopez-Lago","year":"2009","unstructured":"Lopez-Lago MA, Okada T, Murillo MM, Socci N, Giancotti FG (2009) Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling. Mol Cell Biol 29:4235\u20134249","journal-title":"Mol Cell Biol"},{"key":"837_CR88","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-120-3-199402010-00009","volume":"120","author":"CJ Lowenstein","year":"1994","unstructured":"Lowenstein CJ, Dinerman JL, Snyder SH (1994) Nitric oxide: a physiologic messenger. Ann Intern Med 120:227\u2013237","journal-title":"Ann Intern Med"},{"key":"837_CR89","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1186\/1479-5876-10-53","volume":"10","author":"G Madonna","year":"2012","unstructured":"Madonna G, Ullman CD, Gentilcore G, Palmieri G, Ascierto PA (2012) NF-kappaB as potential target in the treatment of melanoma. J Transl Med 10:1479\u20135876","journal-title":"J Transl Med"},{"key":"837_CR90","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1042\/bst0310573","volume":"31","author":"BD Manning","year":"2003","unstructured":"Manning BD, Cantley LC (2003) United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase\/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem Soc Trans 31:573\u2013578","journal-title":"Biochem Soc Trans"},{"key":"837_CR91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/neuonc\/nop1010","volume":"12","author":"VF Mautner","year":"2010","unstructured":"Mautner VF, Nguyen R, Kutta H, Fuensterer C, Bokemeyer C, Hagel C, Friedrich RE, Panse J (2010) Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro-Oncology 12:14\u201318. doi: 10.1093\/neuonc\/nop1010","journal-title":"Neuro-Oncology"},{"key":"837_CR92","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(96)01021-9","volume":"743","author":"WG Mayhan","year":"1996","unstructured":"Mayhan WG (1996) Role of nitric oxide in histamine-induced increases in permeability of the blood-brain barrier. Brain Res 743:70\u201376","journal-title":"Brain Res"},{"key":"837_CR93","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1101\/gad.1335605","volume":"19","author":"AI McClatchey","year":"2005","unstructured":"McClatchey AI, Giovannini M (2005) Membrane organization and tumorigenesis\u2014the NF2 tumor suppressor, merlin. Genes Dev 19:2265\u20132277","journal-title":"Genes Dev"},{"key":"837_CR94","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958\u2013969","journal-title":"Nat Rev Immunol"},{"key":"837_CR95","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.CIR.97.1.99","volume":"97","author":"T Murohara","year":"1998","unstructured":"Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM (1998) Vascular endothelial growth factor\/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97:99\u2013107","journal-title":"Circulation"},{"key":"837_CR96","first-page":"651","volume":"39","author":"S Okamoto","year":"1991","unstructured":"Okamoto S, Takahashi H, Minoura K, Fujita N, Yoshimura M (1991) FDP levels in the cerebrospinal fluid are elevated in patients with meningitis. Rinsho Byori 39:651\u2013655","journal-title":"Rinsho Byori"},{"key":"837_CR97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.molimm.2014.02.020","volume":"63","author":"SA Oldford","year":"2015","unstructured":"Oldford SA, Marshall JS (2015) Mast cells as targets for immunotherapy of solid tumors. Mol Immunol 63:113\u2013124","journal-title":"Mol Immunol"},{"key":"837_CR98","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.4049\/jimmunol.1102187","volume":"188","author":"H Pan","year":"2012","unstructured":"Pan H, O\u2019Brien TF, Zhang P, Zhong XP (2012) The role of tuberous sclerosis complex 1 in regulating innate immunity. J Immunol 188:3658\u20133666","journal-title":"J Immunol"},{"key":"837_CR99","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajpath.2010.11.031","volume":"178","author":"WE Parker","year":"2011","unstructured":"Parker WE, Orlova KA, Heuer GG, Baybis M, Aronica E, Frost M, Wong M, Crino PB (2011) Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex. Am J Pathol 178:296\u2013305","journal-title":"Am J Pathol"},{"key":"837_CR100","doi-asserted-by":"crossref","first-page":"e76746","DOI":"10.1371\/journal.pone.0076746","volume":"8","author":"S Peri","year":"2013","unstructured":"Peri S, Devarajan K, Yang DH, Knudson AG, Balachandran S (2013) Meta-analysis identifies NF-kappaB as a therapeutic target in renal cancer. PLoS One 8:e76746","journal-title":"PLoS One"},{"key":"837_CR101","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/MAO.0b013e31825e73f5","volume":"33","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG 2nd (2012) Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol 33:1046\u20131052","journal-title":"Otol Neurotol"},{"key":"837_CR102","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1750-3639.2012.00616.x","volume":"23","author":"AS Prabowo","year":"2013","unstructured":"Prabowo AS, Anink JJ, Lammens M, Nellist M, van den Ouweland AM, Adle-Biassette H, Sarnat HB, Flores-Sarnat L, Crino PB, Aronica E (2013) Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol 23:45\u201359. doi: 10.1111\/j.1750-3639.2012.00616.x","journal-title":"Brain Pathol"},{"key":"837_CR103","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1073\/pnas.0405971102","volume":"101","author":"R Rong","year":"2004","unstructured":"Rong R, Tang X, Gutmann DH, Ye K (2004) Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L. Proc Natl Acad Sci U S A 101:18200\u201318205","journal-title":"Proc Natl Acad Sci U S A"},{"key":"837_CR104","doi-asserted-by":"crossref","first-page":"e54302","DOI":"10.1371\/journal.pone.0054302","volume":"8","author":"M Ryder","year":"2013","unstructured":"Ryder M, Gild M, Hohl TM, Pamer E, Knauf J, Ghossein R, Joyce JA, Fagin JA (2013) Genetic and pharmacological targeting of CSF-1\/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PLoS One 8:e54302","journal-title":"PLoS One"},{"key":"837_CR105","doi-asserted-by":"crossref","unstructured":"Ryu JK, Petersen MA, Murray SG, Baeten KM, Meyer-Franke A, Chan JP, Vagena E, Bedard C, Machado MR, Rios Coronado PE et al (2015) Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation. Nat Commun 6","DOI":"10.1038\/ncomms9164"},{"key":"837_CR106","doi-asserted-by":"crossref","first-page":"11432","DOI":"10.1158\/0008-5472.CAN-06-1867","volume":"66","author":"A Saccani","year":"2006","unstructured":"Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A, Sica A (2006) p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 66:11432\u201311440","journal-title":"Cancer Res"},{"key":"837_CR107","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.molcel.2011.1003.1017","volume":"42","author":"A Saci","year":"2011","unstructured":"Saci A, Cantley LC, Carpenter CL (2011) Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol Cell 42:50\u201361. doi: 10.1016\/j.molcel.2011.1003.1017","journal-title":"Mol Cell"},{"key":"837_CR108","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1755-3768.2008.01331.x","volume":"88","author":"W Saito","year":"2010","unstructured":"Saito W, Kase S, Ohgami K, Mori S, Ohno S (2010) Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema. Acta Ophthalmol 88:377\u2013380","journal-title":"Acta Ophthalmol"},{"key":"837_CR109","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00011-009-0656-8","volume":"1","author":"E Sakurai","year":"2009","unstructured":"Sakurai E, Watanabe T, Yanai K (2009) Uptake of L-histidine and histamine biosynthesis at the blood-brain barrier. Inflamm Res 1:34\u201335","journal-title":"Inflamm Res"},{"key":"837_CR110","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14:1296\u20131302","journal-title":"Curr Biol"},{"key":"837_CR111","first-page":"30","volume":"937148","author":"JC Sedeyn","year":"2015","unstructured":"Sedeyn JC, Wu H, Hobbs RD, Levin EC, Nagele RG, Venkataraman V (2015) Histamine induces Alzheimer\u2019s disease-like blood brain barrier breach and local cellular responses in mouse brain organotypic cultures. Biomed Res Int 937148:30","journal-title":"Biomed Res Int"},{"key":"837_CR112","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2006.11.021","volume":"46","author":"D Semela","year":"2007","unstructured":"Semela D, Piguet AC, Kolev M, Schmitter K, Hlushchuk R, Djonov V, Stoupis C, Dufour JF (2007) Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma. J Hepatol 46:840\u2013848","journal-title":"J Hepatol"},{"key":"837_CR113","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","volume":"219","author":"DR Senger","year":"1983","unstructured":"Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983\u2013985","journal-title":"Science"},{"key":"837_CR114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/0031302410001671975","volume":"36","author":"M Sharma","year":"2004","unstructured":"Sharma M, Ralte A, Arora R, Santosh V, Shankar SK, Sarkar C (2004) Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Pathology 36:139\u2013144","journal-title":"Pathology"},{"key":"837_CR115","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","volume":"86","author":"G Solinas","year":"2009","unstructured":"Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86:1065\u20131073","journal-title":"J Leukoc Biol"},{"key":"837_CR116","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri2852","volume":"10","author":"L Sorokin","year":"2010","unstructured":"Sorokin L (2010) The impact of the extracellular matrix on inflammation. Nat Rev Immunol 10:712\u2013723","journal-title":"Nat Rev Immunol"},{"key":"837_CR117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvq086","volume":"87","author":"V Spindler","year":"2010","unstructured":"Spindler V, Schlegel N, Waschke J (2010) Role of GTPases in control of microvascular permeability. Cardiovasc Res 87:243\u2013253","journal-title":"Cardiovasc Res"},{"key":"837_CR118","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2741\/1780","volume":"11","author":"S Strukova","year":"2006","unstructured":"Strukova S (2006) Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Front Biosci 11:59\u201380","journal-title":"Front Biosci"},{"key":"837_CR119","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00024382-200005000-00009","volume":"13","author":"Y Suzuki","year":"2000","unstructured":"Suzuki Y, Deitch EA, Mishima S, Duran WN, Xu DZ (2000) Endotoxin-induced mesenteric microvascular changes involve iNOS-derived nitric oxide: results from a study using iNOS knock out mice. Shock 13:397\u2013403","journal-title":"Shock"},{"key":"837_CR120","doi-asserted-by":"crossref","first-page":"42997","DOI":"10.1074\/jbc.M204764200","volume":"277","author":"T Tanimoto","year":"2002","unstructured":"Tanimoto T, Jin ZG, Berk BC (2002) Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1\/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277:42997\u201343001","journal-title":"J Biol Chem"},{"key":"837_CR121","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbadis.2010.1012.1014","volume":"1822","author":"TC Theoharides","year":"2012","unstructured":"Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A et al (2012) Mast cells and inflammation. Biochim Biophys Acta 1822:21\u201333. doi: 10.1016\/j.bbadis.2010.1012.1014","journal-title":"Biochim Biophys Acta"},{"key":"837_CR122","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MOT.0b013e32835a4be2","volume":"17","author":"M Touzot","year":"2012","unstructured":"Touzot M, Soulillou JP, Dantal J (2012) Mechanistic target of rapamycin inhibitors in solid organ transplantation: from benchside to clinical use. Curr Opin Organ Transplant 17:626\u2013633","journal-title":"Curr Opin Organ Transplant"},{"key":"837_CR123","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jnci\/92.7.530","volume":"92","author":"M Tucker","year":"2000","unstructured":"Tucker M, Goldstein A, Dean M, Knudson A (2000) National Cancer Institute workshop report: the phakomatoses revisited. J Natl Cancer Inst 92:530\u2013533","journal-title":"J Natl Cancer Inst"},{"key":"837_CR124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11060-007-9336-0","volume":"83","author":"T Uesaka","year":"2007","unstructured":"Uesaka T, Shono T, Suzuki SO, Nakamizo A, Niiro H, Mizoguchi M, Iwaki T, Sasaki T (2007) Expression of VEGF and its receptor genes in intracranial schwannomas. J Neuro-Oncol 83:259\u2013266","journal-title":"J Neuro-Oncol"},{"key":"837_CR125","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1542\/peds.2004-1336","volume":"115","author":"R Ulloa-Gutierrez","year":"2005","unstructured":"Ulloa-Gutierrez R, Dobson S, Forbes J (2005) Group a streptococcal subdural empyema as a complication of varicella. Pediatrics 115:e112\u2013e114","journal-title":"Pediatrics"},{"key":"837_CR126","doi-asserted-by":"crossref","first-page":"H1296","DOI":"10.1152\/ajpheart.00687.2004","volume":"288","author":"J Waschke","year":"2005","unstructured":"Waschke J, Curry FE, Adamson RH, Drenckhahn D (2005) Regulation of actin dynamics is critical for endothelial barrier functions. Am J Physiol Heart Circ Physiol 288:H1296\u2013H1305","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"837_CR127","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","volume":"15","author":"T Weichhart","year":"2015","unstructured":"Weichhart T, Hengstschlager M, Linke M (2015) Regulation of innate immune cell function by mTOR. Nat Rev Immunol 15:599\u2013614","journal-title":"Nat Rev Immunol"},{"key":"837_CR128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/jcs.01660","volume":"118","author":"K Wennerberg","year":"2005","unstructured":"Wennerberg K, Rossman KL, Der CJ (2005) The Ras superfamily at a glance. J Cell Sci 118:843\u2013846","journal-title":"J Cell Sci"},{"key":"837_CR129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF03401781","volume":"6","author":"R Zamora","year":"2000","unstructured":"Zamora R, Vodovotz Y, Billiar TR (2000) Inducible nitric oxide synthase and inflammatory diseases. Mol Med 6:347\u2013373","journal-title":"Mol Med"},{"key":"837_CR130","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1182\/blood-2006-06-030833","volume":"109","author":"Z Zeng","year":"2007","unstructured":"Zeng Z, Sarbassov dos D, Samudio IJ, Yee KW, Munsell MF, Ellen Jackson C, Giles FJ, Sabatini DM, Andreeff M, Konopleva M (2007) Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood 109:3509\u20133512","journal-title":"Blood"},{"key":"837_CR131","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.04.016","volume":"80","author":"B Zhang","year":"2015","unstructured":"Zhang B, Zou J, Rensing NR, Yang M, Wong M (2015) Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex. Neurobiol Dis 80:70\u201379","journal-title":"Neurobiol Dis"},{"key":"837_CR132","doi-asserted-by":"crossref","unstructured":"Zhu L, Yang T, Li L, Sun L, Hou Y, Hu X, Zhang L, Tian H, Zhao Q, Peng J et al (2014) TSC1 controls macrophage polarization to prevent inflammatory disease. Nat Commun 5","DOI":"10.1038\/ncomms5696"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10143-017-0837-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-017-0837-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-017-0837-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T18:49:25Z","timestamp":1601750965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10143-017-0837-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,11]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1007\/s10143-017-0837-9","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,11]]}}}